Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Imperacerchimera-biotec.com · Low evidenceChimera Biotec provides ultra-sensitive GLP/GCP bioanalytical support for drug development using its proprietary Immuno PCR technology, Imperacer®. The company specializes in developing and validating immunoassays with sub-pg/ml sensitivity for both regulated and discovery-phase research.
Parse Score